Drug Profile
Zidovudine triphosphate mimics
Alternative Names: Azidothymidine mimics; Azidothymidine triphosphate mimics; AZT-mimics; B-108; B-200; B-446; Zidovudine mimicsLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Biota Inc
- Class
- Mechanism of Action DNA-directed DNA polymerase inhibitors; Nucleotide reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; HIV infections
Most Recent Events
- 26 Mar 2007 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 26 Mar 2007 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
- 31 May 2004 Data presented at the 17th International Conference on Antiviral Research (ICAR-2004) have been added to the Viral Infections antimicrobial activity section